Enbridge Inc. Q2 FY26 Earnings Analysis
Published 29 May 2026 | Oil, Gas and Consumable Fuels | Market Cap: ₹1.2L Cr
Price
₹55.56
Market Cap
₹1.2L Cr
P/E Ratio
26.6
Revenue Rank
Margin Rank
Earnings Summary
- Enbridge reaffirms a 5% average annual growth rate in EBITDA, DCF per share, and EPS through 2026 and beyond, extending through 2030. - Enbridge reaffirms a 5% average annual growth rate for EBITDA, DCF per share, and EPS through 2026 and extending through to 2030.
📊 Revenue & Sales Performance
Rank 3- Enbridge reaffirms a 5% average annual growth rate in EBITDA, DCF per share, and EPS through 2026 and beyond, extending through 2030. - A $40 billion capital backlog supports visible growth through 2033. - Liquids Pipelines: Advancing 430,000 barrels per day incremental capacity by 2028, with strong export growth driven by projects like Gray Oak expansion and Ingleside storage. - Gas Transmission: Over $10 billion in near-term growth opportunities, including expansions like Tres Palacios (25 Bcf storage by 2030) and Vector pipeline expansions in 2028. - Gas Distribution: Expected rate base growth of 5% annually through 2029. - Renewables: Expanding with 1.5 GW of additional safe harbor renewable projects and continued partnership growth with Meta exceeding 1 GW. - Storage expansions underway; nearly $1 billion invested in gas storage expansions to meet rising demand. - Overall, Enbridge projects consistent, long-term growth supported by regulated and contracted assets.
📈 Profitability & Margins
Rank 3- Enbridge reaffirms a 5% average annual growth rate for EBITDA, DCF per share, and EPS through 2026 and extending through to 2030. - Growth guidance was originally provided about 14 months ago (March 2025) and remains unchanged; no guidance beyond 2030 has been set yet. - The company expects steady, visible growth driven by a $40 billion capital backlog extending through 2033. - Rate base for utilities is projected to grow at 5% annually through 2029, with some U.S. utilities potentially exceeding 8% CAGR through 2029. - Organic growth is a key focus with disciplined brownfield investments and pipeline expansions. - Strong cash flows, diverse asset base, and regulated, predictable revenue streams support this growth outlook. - Enbridge plans to update guidance at their next Investor Day, likely fall 2026 or early 2027.
🏗️ Capital Expenditure Plans
Yes- Advancing $40 billion capital backlog supporting growth through 2033, focusing on accretive brownfield opportunities. - Near-term growth opportunities include $10 billion to $20 billion planned for FID in next 22 months. - Liquids Pipelines: Advancing 430,000 barrels/day incremental mainline and express capacity by 2028, including Mainline Optimization Phase 2 adding 250,000 barrels/day WCSB egress by 2028. - Ingleside storage expansion increased capacity to ~20 million barrels; Gray Oak expansion completed, boosting export capacity over 1 million barrels/day. - Gas Transmission: Building Tres Palacios expansion (~25 Bcf gas storage, $400 million capex) with phased service 2028-2030. - Vector pipeline expansion ($100 million+, 400 million cubic feet/day) targeted for 2028 in-service; evaluating further expansions after successful open seasons. - Over $1 billion investment in gas storage expansion (Gulf Coast and Canada). - Continued focus on disciplined capital allocation supported by equity self-funding and strong balance sheet.
💰 Fundraising & Capital Structure
Yes- There is no explicit mention of new fundraising activities through debt or equity in the provided pages. - The company emphasizes continued equity self-funding for capital allocation in 2026. - Strong balance sheet and disciplined capital allocation are highlighted, supporting ongoing investments. - The business model focuses on returning capital via dividends, with $40 billion expected to be returned to shareholders over the next 5 years. - Growth is supported by internally generated equity and balance sheet capacity, suggesting reliance primarily on internal funds rather than new external fundraising. - No specific plans for issuing new debt or equity were detailed in the excerpts.
📋 Order Book & Pipeline
Yes- The company has a $40 billion capital backlog extending through 2033, providing strong long-term growth visibility. - Near-term growth opportunities of $10 billion to $20 billion are planned for FID within the next 22-24 months, drawn from a larger $50 billion opportunity set. - The $50 billion opportunity set remains steady despite recent project sanctions, with continuous additions keeping the pipeline full. - Several projects have reached FID recently, including the Tres Palacios expansion ($400 million, 2028-2030 service) and the Vector pipeline expansion (~$100 million, 2028 service). - Binding open seasons are ongoing for incremental capacities, e.g., 200,000 bpd FSP and 50,000 bpd Southern Access extension to support MLO2. - Ingleside storage expansion and Gray Oak pipeline expansion are completed, enhancing export capacity. - The firm anticipates continuing to bring new projects forward every quarter to build backlog and EBITDA.
Key Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Frequently Asked Questions
What were Enbridge Inc. Q2 FY26 results?
- Enbridge reaffirms a 5% average annual growth rate in EBITDA, DCF per share, and EPS through 2026 and beyond, extending through 2030. - Enbridge reaffirms a 5% average annual growth rate for EBITDA, DCF per share, and EPS through 2026 and extending through to 2030.
What is Enbridge Inc. share price analysis?
Enbridge Inc. currently shows a below-average growth signal. The stock trades at a P/E of 26.6 with a market cap of $121,321. Investors should review the full earnings analysis for detailed insights.
Is Enbridge Inc. planning capital expenditure?
- Advancing $40 billion capital backlog supporting growth through 2033, focusing on accretive brownfield opportunities.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
